The ECMO heart and lung machine boosts survival among pregnant women with severe PAH, according to a case series and ...

Tadliq is a liquid formulation of tadalafil approved in the U.S. to improve exercise ability in people with pulmonary ...

As the world marks Rare Disease Month, health experts are calling attention to conditions that often go unnoticed—despite their life-threatening impact. One such condition is Pulmonary Arterial ...

SAN ANTONIO — Patients given higher doses of oral and subcutaneous treprostinil experience a significantly longer time before their first pulmonary arterial hypertension (PAH)-related and all-cause ...

Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.

Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR ™ (sotatercept-csrk) compared to ...

Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) prevalence is higher among Medicaid beneficiaries, with significant racial and ethnic disparities, particularly affecting Black ...

The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

As the world marks Rare Disease Month, health experts are urging greater awareness of conditions that often go unnoticed ...

WINREVAIR significantly reduced the risk of major morbidity and mortality events, the primary endpoint, in adults with PAH (Group 1 PH) WHO* functional class (FC) III or IV at high risk of mortality ...